Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy
- 13 June 2022
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 18 (22) , 2425-2439
Abstract
Objective: The aim of this study was to investigate quality-of-life (QoL) in breast cancer (BC) patients treated with adjuvant endocrine therapy (AET). Methods: We designed a cross-sectional study ... Plain language summary Breast cancer (BC) remains the most common cancer among women worldwide. Hormone receptor-positive (estrogen receptor- and/or progesterone receptor-positive) BC represents 70...Keywords
This publication has 37 references indexed in Scilit:
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialThe Lancet, 2013
- Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyBreast Cancer Research and Treatment, 2012
- Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors: A Systematic ReviewJNCI: Journal of the National Cancer Institute, 2012
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysisJNCI: Journal of the National Cancer Institute, 2011
- Quality of Life After Breast Cancer Diagnosis and SurvivalJournal of Clinical Oncology, 2011
- Quality of Life in the Intergroup Exemestane Study: A Randomized Trial of Exemestane Versus Continued Tamoxifen After 2 to 3 Years of Tamoxifen in Postmenopausal Women With Primary Breast CancerJournal of Clinical Oncology, 2006
- Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI: Journal of the National Cancer Institute, 2005
- Quality of life among long-term breast cancer survivors: A systematic reviewEuropean Journal of Cancer, 2005
- Quality of Life of Postmenopausal Women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer TrialJournal of Clinical Oncology, 2004
- Age-related differences in the quality of life of breast carcinoma patients after treatmentCancer, 1999